Sulthiame in childhood epilepsy

Pediatrics International

Volumn 46, Issue 5, 2004, Pages 521-524

  Ben Zeev, Bruria ^a,c   Watemberg, Nathan ^b,c   Lerman, Pinchas ^c   Barash, Itshak ^c   Brand, Nathan ^a,c   Lerman Sagie, Tally ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiepileptic drugs; Benign partial epilepsy of childhood; Epilepsy; Juvenile myoclonic epilepsy; Sulthiame

Indexed keywords

ANTICONVULSIVE AGENT; SULTIAME;

ADOLESCENT; ADULT; ANOREXIA; ANTICONVULSANT THERAPY; BENIGN CHILDHOOD EPILEPSY; CHILD; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEAR; FEMALE; HEADACHE; HUMAN; HYPERVENTILATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONOTHERAPY; MYOCLONUS EPILEPSY; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; GERMANY; HUMANS; HYPERVENTILATION; IRELAND; ISRAEL; MALE; MAXIMUM TOLERATED DOSE; PARESTHESIA; RETROSPECTIVE STUDIES; THIAZINES; TREATMENT OUTCOME;

EID: 7044249708     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.01954.x     Document Type: Review

References (23)

1. Ingram TTS, Ratcliffe SG. Clinical trial of Ospolot in epilepsy. Dev. Med. Child Neurol. 1963; 5: 313-8.
2. Gordon N. The use of Ospolot in the treatment of epilepsy. Epilepsia 1964; 5: 68-73.
3. Green JR, Troupin AS, Halpern LM, Friel P, Kanarek P. Sulthiame: evaluafion as an anficonvulsant. Epilepsia 1974; 15: 329-49.
4. Doose H, Baier WK, Ernst JP, Tuxhorn I, Volzke E. Benign partial epilepsy-treatment with sulthiame. Dev. Med. Child Neurol. 1988; 30: 683-4.
5. Gross-Selbeck G. Treatment of 'benign' partial epilepsies of childhood, including atypical forms. Neuropediatrics 1995; 26: 45-50.
6. Kramer U, Shahar E, Zelnuk N et al. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes. J. Child Neurol. 2002; 17: 914-6.
7. Lerman P, Nussbaum E. The use of sulthiame- in myoclonic epilepsy of childhood and adolescence. Acta Neurol. Scand. Suppl. 1975; 60: 7-12.
8. Livingston S, Villamater C, Sakata Y. Ospolot (sulthiame) in epilepsy. Dis. Nerv. Syst. 1967; 28: 259-63.
9. Mann P, Ecker T, Tyrer JH, Sutherland JM. Treatment of temporal lobe epilepsy with sulthiame (Ospolot). A follow-up study. Med. J. Aust. 1967; 2: 729-31
10. Lerman P, Lerman-Sagie T. Sulthiame revisited. J. Child Neurol. 1995; 10: 241-2.
11. Dulac O, Bouguerra L, Rey E, de Lauture D, Arthuis M. Monotherapy with carbamazepine in childhood epilepsies. Arch. Fr. Pediatr. 1983; 40: 415-9.
12. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39 (Suppl. 3): S2-10.
13. Prasad AN, Stefanelli M, Nagarajan L. Seizure exacerbation and developmental regression with carbamazepine. Can. J. Neurol. Sci. 1998; 25: 287-94.
14. Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989; 30 (Suppl. 4): S19-23.
15. Dreifuss FE. Juvenile myoclonic epilepsy: characteristics of a primary generalized epilepsy. Epilepsia 1989; 30 (Suppl. 4): S1-7.
16. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994; 35: 285-96.
17. Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 1996; 5: 149-51.
18. Vainionpaa LK, Rattya J, Knip M et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann. Neurol. 1999; 4: 444-50.
19. Binnie CD, Marston D. Cognitive correlates of interictal discharge. Epilepsia 1992; 33 (Suppl. 6): S11-7.
20. Marciani MG, Spanedda F, Bassetti MA et al. Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: a computerized analysis. Br. J. Clin. Pharmacol. 1996; 42: 621-7.
21. Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Epilepsia 2000; 41: 1284-8.
22. Bast T, Volp A, Wolf C. The influence of sulthiame on EEG in children with Benign childhood epilepsy with centrotemporal spikes (BECTS). Epilepsia 2003; 44: 215-20.
23. Engler F, Maeder-Ingvar M, Roulet E, Deonna T. Treatment of sulthiame in benign partial epilepsy of childhood and related syndromes: an open clinical and EEG study. Neuropediatrics 2003; 34: 105-9.